BioCentury
ARTICLE | Financial News

Mirati Therapeutics amends follow-on

October 21, 2013 7:00 AM UTC

Mirati Therapeutics Inc. (NASDAQ:MRTX), San Diego, Calif. Business: Cancer, Infectious Date announced: 10/16/13 Type: Follow-on To be raised: Up to $57.5 million Shares: 3 million Price prior: $16.42 ...